Table 2 Characteristics of patients in the training and validation sets at baseline
Variable | Training set (n = 184) | Validation set (n = 71) | P value |
|---|---|---|---|
Age (years) | 53 (49, 58) | 54 (48, 62) | 0.432 |
Male sex (%) | 130 (70.7%) | 55 (77.5%) | 0.275 |
WBC (109/L) | 3.64 (2.22, 5.50) | 3.31 (2.37, 5.03) | 0.415 |
NLR | 2.47 (1.67, 4.54) | 2.50 (1.50, 4.50) | 0.690 |
Hb (g/L) | 102.85 ± 24.573 | 104.39 ± 245.724 | 0.657 |
PLT (109/L) | 65 (43, 88) | 60 (42, 111) | 0.740 |
ALB (g/L) | 28.15 (24.50, 32.58) | 27.9 (25, 31.9) | 0.836 |
GLB (g/L) | 30.35 (27.05, 35.25) | 31.10 (26.70, 36.40) | 0.509 |
ALT (U/L) | 26 (20, 42) | 29.00 (20.00, 44.00) | 0.556 |
AST (U/L) | 39 (29, 63) | 42.00 (31.00, 74.00) | 0.352 |
TB (µmol/L) | 35.95 (21.525, 77.975) | 34.3 (21.8, 65.90) | 0.709 |
BUN (mmol/L) | 5.02 (3.93, 7.19) | 4.83 (3.84, 6.06) | 0.187 |
Cr (µmol/L) | 74.45 (63.4, 91.425) | 74.10 (65.10, 84.50) | 0.602 |
Na+ (mmol/L) | 139.70 (136.8, 141.50) | 139.70 (137.90, 141.00) | 0.648 |
PT(s) | 15.95 (14.025, 17.8) | 16.10 (14.00, 18.10) | 0.796 |
INR | 1.48 (1.2725, 1.68) | 1.47 (1.28, 1.67) | 0.928 |
APTT (s) | 36.25 (30.625, 42.475) | 34.80 (31.10, 41.00) | 0.655 |
Use of diuretics (%) | 115 (62.5%) | 50 (70.4%) | 0.235 |
EGVB (%) | 31 (16.8%) | 10 (14.1%) | 0.590 |
Bacterial infection (%) | 74 (40.4%) | 34 (47.9%) | 0.281 |